Esomeprazole 40 mg Administered Intravenously Has Similar Safety and Efficacy Profiles to the Oral Formulation in Patients with Erosive Esophagitis

By  

Digestion, Vol. 70, Iss. 4, 2005-03 ,pp. : 250-256

Karger

Access to resources Recommend Favorite

Novel Measurement of Rapid Treatment Success with ReQuest^TM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

By  

Digestion, Vol. 75, Iss. 1, 2007-05 ,pp. : 62-68

Karger

Access to resources Recommend Favorite

Novel Measurement of Rapid Treatment Success with ReQuest^TM: First and Sustained Symptom Relief as Outcome Parameters in Patients with Endoscopy-Negative GERD Receiving 20 mg Pantoprazole or 20 mg Esomeprazole

By  

Digestion, Vol. 71, Iss. 3, 2005-06 ,pp. : 152-158

Karger

Access to resources Recommend Favorite

The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan

By Kinoshita Yoshikazu   Kobayashi Takeaki   Kato Mototsugu   Asahina Kan   Haruma Ken   Shimatani Tomohiko   Inoue Shuji   Kabemura Teppei   Kurosawa Susumu   Kuwayama Hajime   Ashida Kiyoshi   Hirayama Michiaki   Kiyama Satoshi   Yamamoto Munemitsu   Suzuki Junichi   Suzuki Hiroyuki   Matsumoto Katsuhiko   Aoshima Masaru  

Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 554-561

Springer Publishing Company

Access to resources Recommend Favorite

Potent Gastric Acid Inhibition Over 24 Hours by 4-Times Daily Dosing of Esomeprazole 20 mg

By  

Digestion, Vol. 91, Iss. 4, 2015-04 ,pp. : 277-285

Karger

Access to resources Recommend Favorite